Even as the Congress leadership is boggled with its Karnataka conundrum, reports indicate that the party may end up with the ...

Get More information on nityanand rai including breaking news and opinion. Check News articles, photos, videos of nityanand ...

The UK's Office for Nuclear Regulation has granted the Hinkley Point B nuclear power plant in Somerset Fuel Free Verification ...

Mr Muralidhar’s contention cannot be dismissed; but an assessment of the court’s agility cannot be based on the perception of ...

- Rapid increase in diagnosis of ADH1 with >1,700 unique patients identified since October 2023; BridgeBio intends to submit an NDA to the FDA based on results from CALIBRATE, the Company’s Phase 3 ...

Assam and the North-East have always contributed bravehearts to the nation. From gallantry award winners to senior commanders ...

LAWMAKERS RETURN. THE CALIFORNIA LEGISLATURE THIS WEEK APPROVING A BILL THAT WOULD BAN STATE LAWMAKERS FROM SIGNING NON-DISCLOSURE AGREEMENTS WHEN DECIDING ON HOW TO USE TAXPAYER DOLLARS OR CREATE ...

LEAD TO JUSTICE. AND WE’RE GOING TO START AT SIX WITH A LIVE LOOK AT THE STATE CAPITOL, WHERE KCRA THREE INVESTIGATES A $1 BILLION PROJECT THAT HAS BEEN SHROUDED IN SECRECY. THE WORK ON THE CAPITOL ...

AXS-12's clinical development program in narcolepsy includes three controlled efficacy trials, and a completed long-term safety trial. The drug has already been granted orphan drug designation, a ...

Hutchmed (China) Limited, an innovative, commercial-stage, biopharmaceutical company, announces that the New Drug Application (NDA) for fanregratinib (HMPL-453) for the treatment of adult patients ...

— NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 — ...

— Savolitinib has the potential to become the first selective MET inhibitor in China for MET-amplified gastric cancer — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- ...